°Ë»ö°á°ú: ÃÑ 30°³ Áß 21 - 34 |
¸íÀÎÆä´ÏÅäÀÎÁ¤100mg(Æä´ÏÅäÀÎ)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°
Á¦Ç°¸í | ¼ººÐ¸í | ÁÖ¼ººÐÄÚµå¡ã | Ç¥ÁØÄÚµå | ÆǸŻç | °í½Ã¹øÈ£ | Àû¿ëÀÏ |
Á¨º¸¾ßÁ¤_(1Á¤) | cobicistat silicon dioxide (as cobicistat) | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
Á¨º¸¾ßÁ¤_(1Á¤) | elvitegravir | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
Á¨º¸¾ßÁ¤_(1Á¤) | emtricitabine | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
Á¨º¸¾ßÁ¤_(1Á¤) | tenofovir alafenamide fumarate (as tenofovir alafenamide) | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
¸¶ºñ·¿Á¤_(1Á¤) | glecaprevir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
¸¶ºñ·¿Á¤_(1Á¤) | pibrentasvir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
·ÎºñÅ¥¾ÆÁ¤25¹Ð¸®±×·¥(·Ñ¶óƼ´Õ)_(25mg/Á¤) | lorlatinib | 699701ATB | 648903610 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240030 | 20240625 |
·ÎºñÅ¥¾ÆÁ¤100¹Ð¸®±×·¥(·Ñ¶óƼ´Õ)_(0.1g/Á¤) | lorlatinib | 699702ATB | 648903620 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240030 | 20240625 |
ÆŽº·Îºñµå(´Ï¸£¸¶Æ®·¼ºñ¸£, ¸®Å䳪ºñ¸£)_(30Á¤) | nirmatrelvir | 703500ATB | 648903860 | Çѱ¹ÈÀÌÀÚÁ¦¾à¢ß | 20210113 | 20211230 |
ÆŽº·Îºñµå(´Ï¸£¸¶Æ®·¼ºñ¸£, ¸®Å䳪ºñ¸£)_(30Á¤) | ritonavir | 703500ATB | 648903860 | Çѱ¹ÈÀÌÀÚÁ¦¾à¢ß | 20210113 | 20211230 |
º¸Ä«ºê¸®¾ÆÁ¤30¹Ð¸®±×·¥(Ä«º¸Åױ׶óºñ¸£³ªÆ®·ý)_(31.62mg/1Á¤) | cabotegravir sodium (as cabotegravir) | 707201ATB | 650003230 | (ÁÖ)±Û¶ô¼Ò½º¹Ì½ºÅ¬¶óÀÎ | 20240030 | 20240625 |
Àη¹ºòĸ½¶(Æäµå¶óƼ´Õ¿°»ê¿°¼öȹ°)_(0.1173g/1ĸ½¶) | fedratinib dihydrochloride monohydrate (as fedratinib) | 708701ACH | 658700730 | (À¯)Çѱ¹ºñ¿¥¿¡½ºÁ¦¾à | 20240030 | 20240625 |
ÄÉ·»µð¾ÆÁ¤10¹Ð¸®±×·¥(Çdz׷¹³í)_(10mg/1Á¤) | finerenone | 729201ATB | 641106200 | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 20240030 | 20240625 |
ÄÉ·»µð¾ÆÁ¤20¹Ð¸®±×·¥(Çdz׷¹³í)_(20mg/1Á¤) | finerenone | 729202ATB | 641106190 | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 20240030 | 20240625 |